- Home
- DRRX vs AXDX Comparison
DRRX vs AXDX Comparison
Compare DRRX & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- AXDX
- Stock Information
- Founded
- DRRX 1998
- AXDX 1982
- Country
- DRRX United States
- AXDX United States
- Employees
- DRRX N/A
- AXDX N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- AXDX Biotechnology: Laboratory Analytical Instruments
- Sector
- DRRX Health Care
- AXDX Industrials
- Exchange
- DRRX Nasdaq
- AXDX Nasdaq
- Market Cap
- DRRX 26.3M
- AXDX 28.3M
- IPO Year
- DRRX 2000
- AXDX 1996
- Fundamental
- Price
- DRRX $0.75
- AXDX $1.31
- Analyst Decision
- DRRX Buy
- AXDX Hold
- Analyst Count
- DRRX 2
- AXDX 1
- Target Price
- DRRX $5.00
- AXDX $1.00
- AVG Volume (30 Days)
- DRRX 67.3K
- AXDX 44.1K
- Earning Date
- DRRX 03-26-2025
- AXDX 03-27-2025
- Dividend Yield
- DRRX N/A
- AXDX N/A
- EPS Growth
- DRRX N/A
- AXDX N/A
- EPS
- DRRX N/A
- AXDX N/A
- Revenue
- DRRX $8,594,000.00
- AXDX $11,909,000.00
- Revenue This Year
- DRRX $54.32
- AXDX $0.66
- Revenue Next Year
- DRRX N/A
- AXDX $3.36
- P/E Ratio
- DRRX N/A
- AXDX N/A
- Revenue Growth
- DRRX N/A
- AXDX N/A
- 52 Week Low
- DRRX $0.68
- AXDX $0.73
- 52 Week High
- DRRX $1.88
- AXDX $2.09
- Technical
- Relative Strength Index (RSI)
- DRRX 38.86
- AXDX 53.72
- Support Level
- DRRX $0.71
- AXDX $1.27
- Resistance Level
- DRRX $0.85
- AXDX $1.37
- Average True Range (ATR)
- DRRX 0.06
- AXDX 0.09
- MACD
- DRRX -0.01
- AXDX 0.03
- Stochastic Oscillator
- DRRX 26.38
- AXDX 74.29
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.